REQUEST A DEMO
Total
USD $0.00
Search more companies

Prestige Biologics Co., Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Prestige Biologics Co., Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Prestige Biologics Co., Ltd. is an enterprise based in South Korea. Its main office is in Cheongju. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on June 02, 2015. 211 (2024) employees currently work for Prestige Biologics Co., Ltd.. There was a net sales revenue increase of 241.37% reported in Prestige Biologics Co., Ltd.’s latest financial highlights for Q12026. Over the same period, its total assets decreased by 19.66%. The net profit margin of Prestige Biologics Co., Ltd. increased by 1652.75% in 2026.

Headquarters
197, Osongsaengmyeong 1-Ro, Osong-Eup, Heungdeok-Gu
Cheongju; Chungcheongbuk;

Contact Details: Purchase the Prestige Biologics Co., Ltd. report to view the information.

Website: http://www.prestigebiologics.com

Basic Information
Total Employees:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Registered Capital:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Prestige Biologics Co., Ltd. report to view the information.
Incorporation Date:
June 02, 2015
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
프레스티지바이오로직스(주)
프레스티지바이오파마
Company Performance
Financial values in the chart are available after Prestige Biologics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
241.37%
Total Operating Revenue
323.32%
Operating Profit
-40.62%
EBITDA
-52.99%
Net Profit/Loss for the Period
-36.91%
Total Assets
-19.66%
Total Equity
-21.14%
Operating Profit Margin
1585.22%
Net Profit Margin
1652.75%
Return on Equity (ROE)
-4.49%
Debt / Equity
8.3%
Quick Ratio
-0.48%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?